News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Spot gold softer in thin trade as oil rebound, U.S.-Iran uncertainty cloud rate outlook
Kitco·2026/05/04 13:45
NZD: RBNZ pushes back on supply-shock hikes – BNY
FXStreet·2026/05/04 13:42
BoC: Policy on extended hold – TD Securities
FXStreet·2026/05/04 13:42
Bitcoin jumps 20 percent in 30 days without clear catalyst
Cointurk·2026/05/04 13:39
Crypto Expert Shares Full Market Prediction Focusing on BTC and ETH Prices for 2026-2027
Cryptonewsland·2026/05/04 13:39
Bitcoin Tests Crucial $80,000 Resistance: One Move Could Change Everything
Newsbtc·2026/05/04 13:36
Five Takeaways From Berkshire CEO Greg Abel's First Annual Shareholder Meeting as Host
moomoo-证劵·2026/05/04 13:31
Euro area: Weak confidence clouds activity outlook – Societe Generale
FXStreet·2026/05/04 13:30
Solana dips below $100 for 88 days as BTC weakness persists
Cointurk·2026/05/04 13:21
How Canton Network Lets Institutions Guard Against DeFi Security Risks: Digital Asset CEO
Decrypt·2026/05/04 13:20
Flash
14:45
After its request for reconsideration was rejected by Nasdaq, Oriental Rise Holdings Ltd. is now seeking to appeal the exchange's delisting decision.The company's move aims to challenge the exchange's decision to uphold its delisting through a formal appeals process.
14:42
"Maji Big Brother" sold a Bored Ape NFT and used the proceeds to add margin to a Hyperliquid account.According to Foresight News, Arkham monitoring shows that "Machi Big Brother" sold one of his 150 Bored Ape holdings and used the proceeds to add margin to his Hyperliquid account. He now holds a $67,000 margin and has opened a $1.6 million ETH long position.
14:40
US stocks move: Eli Lilly surges over 6% to a record high as leukemia drug Jaypirca receives positive recommendation from the European Union’s CHMPGolden Globe June 26｜A certain exchange surged by more than 6%, reaching $1,200.55, marking a record high. In terms of news, the company announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of its non-covalent Bruton’s tyrosine kinase (BTK) inhibitor Jaypirca, for the treatment of adult chronic lymphocytic leukemia (CLL) patients who have received or not received BTK inhibitor therapy. This recommendation covers the entire line of treatment for this indication.